Eli Lilly LLY
NYSE LLY
$1,422.72 +10.77 (+0.76%)
As of: Nov 10, 2026 · 12:46 PM EST

Eli Lilly (LLY) Operating Leases (2019)

Updated

Analysis

Eli Lilly (LLY) Operating Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 486.70 Mn
Sep 30, 2019 485.20 Mn
Jun 30, 2019 503.30 Mn
Mar 31, 2019 508.20 Mn
API Access

Eli Lilly Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=LLY&period=max&api_key=YOUR_API_KEY